Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice

Interleukin 12: still a promising candidate for tumor immunotherapy?

(2014) Witold Lasek et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Shaping the repertoire of tumor-infiltrating effector and regulatory T cells

(2014) Peter A. Savage et al.   IMMUNOLOGICAL REVIEWS

Tumor antigen-specific CD4+T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies

(2014) M. P. Protti et al.   TISSUE ANTIGENS

The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling

(2014) Christian Stockmann et al.   Frontiers in Oncology

Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF121 Combined with IL-12 Gene Therapy

(2013) Agnieszka Ciomber et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Clinical evaluation of systemic and local immune responses in cancer: time for integration

(2013) Dmitriy W. Gutkin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune-suppressive properties of the tumor microenvironment

(2013) Jürgen C. Becker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy

(2013) Y. Huang et al.   CANCER RESEARCH

Therapeutic gene modified cell based cancer vaccines

(2013) Anna Kozłowska et al.   GENE

Antiangiogenic Therapies: Going beyond Their Limits

(2013) L. Moserle et al.   Cancer Discovery

Dendritic Cells in the Cancer Microenvironment

(2013) Yang Ma et al.   Journal of Cancer

The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy

(2012) Ryszard Smolarczyk et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy

(2012) M. A. Swartz et al.   CANCER RESEARCH

T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

(2012) A. Facciabene et al.   CANCER RESEARCH

Modulation of Immunity by Antiangiogenic Molecules in Cancer

(2012) Magali Terme et al.   Clinical & Developmental Immunology

Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents

(2012) M Jarosz et al.   GENE THERAPY

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

(2012) Y. Huang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

(2011) Eric Tartour et al.   CANCER AND METASTASIS REVIEWS

Regulatory dendritic cells in the tumor immunoenvironment

(2011) Galina V. Shurin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

(2011) J. Fucikova et al.   CANCER RESEARCH

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

(2011) Olivier Keunen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?

(2010) Stanisław Szala et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Mechanisms of resistance to antiangiogenesis therapy

(2010) Faisal Azam et al.   EUROPEAN JOURNAL OF CANCER

Anticancer effects of CAMEL peptide

(2010) Ryszard Smolarczyk et al.   LABORATORY INVESTIGATION

Whole tumor antigen vaccines

(2010) Cheryl Lai-Lai Chiang et al.   SEMINARS IN IMMUNOLOGY

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Natural killer cell is a major producer of interferon γ that is critical for the IL-12-induced anti-tumor effect in mice

(2009) Akio Uemura et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

(2009) J. Ozao-Choy et al.   CANCER RESEARCH

The angiogenic switch in carcinogenesis

(2009) Vanessa Baeriswyl et al.   SEMINARS IN CANCER BIOLOGY

Immune surveillance: a balance between protumor and antitumor immunity

(2008) Suzanne Ostrand-Rosenberg   CURRENT OPINION IN GENETICS & DEVELOPMENT

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE